Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
More than a dozen medical devices registered with the FDA for export to other countries — but not for use in the U.S. — have been identified as having "troubled track records" in an investigation by NBC News.
Between the lines: This raises questions about whether it is America's job to evaluate whether a medical device is safe for use in another country. But it also shows what can happen if health care companies are left alone to decide between consumer safety and profit.
Details:
- These devices include heart valves that caused severe infections, shoulder implants that needed to be removed and stents that could cut into arteries that they were supposed to save.
- There are about 4,600 devices registered with the FDA as "export-only," and American companies made more than $41 billion last year on exporting medical devices.
- Some of the companies that make the devices identified by NBC failed to report serious adverse events.